Directory Image
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.

Metabolic Disorder Drugs Market Forecasted a Rapid Growth as per TBRC’s Latest Growth

Author: Aleemuddin Tbrc
by Aleemuddin Tbrc
Posted: Dec 20, 2018

The global metabolic disorder market, one of the segments of healthcare services industry. During the historic period it grew at a compound annual growth rate (CAGR) of around 12%. This was mainly due to growing diabetic population worldwide, and increasing academia-industry collaborations to develop new drugs for treatment of metabolic disorders

For the forecasted period, the metabolic disorder market size is expected to be over $124 billion by 2021, growing at a CAGR of nearly 10%. The market is expected to be driven by rapid growth in diabetic patients which, according to the World Health Organization, is expected to be the world’s seventh leading cause of death in 2030

Find TBRC’s report on the batteries manufacturing market:

https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report-2018

Drug manufacturers are developing various anti-diabetic drugs for type-2 diabetes treatment. Type 2 diabetes is a noninsulin-dependent diabetes that affects sugar (glucose) metabolism of the patient by either resisting or restricting the effects of insulin. In July 2017, researchers at the University of California found that Amlexanox, a repurposed asthma drug with anti-inflammatory and anti-allergic properties, can improve blood sugar levels in type 2 diabetic patients.

Download a sample report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=277&type=smp

The metabolic disorders drugs market covers medications that are used in the treatment of metabolic diseases such as diabetes, thyroid, hyperparathyroidism, hypopituitarism, and hypoadrenalism. Some of the major drugs used in the treatment of metabolic diseases are Insulin, Methimazole, and Calcimimetics.

The top five companies covered are Sanofi S.A., Novo Nordisk A/S, AstraZeneca Plc., Johnson & Johnson and Merck & Co. Sanofi was the largest competitor in the metabolic disorder drugs market in 2017.

The countries covered are USA, China, Germany, Brazil, Japan, UK, Spain, Russia, France, Australia, Italy, India and rest of the world.

The metabolic disorders drugs industry is segmented into Anti-Diabetics Drugs, Anti-Thyroid Drugs and Other (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism) Drugs.

Anti-Diabetics Drugs companies produce drugs that can be used to manage diabetes by stabilizing and controlling blood glucose levels in diabetic patients. Some of the major anti-diabetics drugs include insulin, pramlintide (amylin), GLP-1 receptor agonists (such as Byetta and Victoza), and oral hypoglycemics (tablets).

Anti-Thyroid Drugs companies produce drugs that can be used for treatment of an overactive thyroid (hyperthyroidism) caused by Graves' disease. These drugs are also called thionamides and some of its major examples include methimazole and propylthiouracil.

Other (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism) Drugs companies produce drugs for the treatment of disorders related to parathyroid glands, pituitary glands, and adrenal glands. Some of the major examples of hyperparathyroidism, hypopituitarism, hypoadrenalism drugs include calcimimetics and corticosteroids.

About The Business Research Company.

The Business Research Company is a market research and intelligence company, which excels in company, market and consumer research.

It has research professionals at its offices in the UK, India and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, chemicals and technology.

The Business Research Company's management has more than 20 years of varied business research experience. They have delivered hundreds of research projects to the senior management of some of the world's largest organizations.

Contact Information.

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company

About the Author

The Business Research Company excels in company, market and consumer research. Our team consists of 90+ professionals working to create high quality market reports that can either be accessed through our research center.

Rate this Article
Leave a Comment
Author Thumbnail
I Agree:
Comment 
Pictures
Author: Aleemuddin Tbrc

Aleemuddin Tbrc

Member since: Nov 13, 2018
Published articles: 473

Related Articles